arrow
A

Alessia Beccacece

IRCCS INRCA
H指数:12
被引数:445

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From necroptosis to neuroinflammation: Unraveling mechanisms and therapeutic targets in age-related cognitive decline

从坏死性凋亡到神经炎症:揭示年龄相关认知衰退的机制和 therapeutic targets

2026-04-280
OAAI
Pharmaceutical Strategies for West Nile Virus in Europe, an Underrecognized Cause of Severe Disease and Mortality in Older Adults: From Supportive Care to Antiviral Development

欧洲西尼罗病毒(West Nile Virus)的药物治疗策略:一种在老年人中未被充分认识的重症疾病和死亡原因——从支持性治疗到抗病毒药物开发

2026-02-120
OAAI
Geriatric Telemanagement of Health Conditions (GET HEALTH) in Nursing Home Residents Recently Discharged From the Hospital: Protocol for a Before-After Study

住院后近期出院的养老院居民健康问题远程管理(GET HEALTH):一项前后对照研究方案

2026-01-010
PRE
Outcome measures for health interventions targeting multimorbid older adults: A systematic review.

针对多病共存老年人群的健康干预措施结局指标:一项系统综述。

2025-11-140
PRE
Anticholinergic drug exposure is associated with prevalence, worsening and incidence of dysphagia among hospitalized older adults
2025-05-010
OAAI
Efficacy of a Multistrain Synbiotic Treatment in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled Randomized Trial
2024-07-161
OAAI
Predictors of Mortality and Orotracheal Intubation in Patients with Pulmonary Barotrauma Due to COVID-19: An Italian Multicenter Observational Study during Two Years of the Pandemic
2024-03-150
OAAI
Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination

评估历史性天花疫苗接种对Mpox病毒的交叉免疫力

2023-09-2811
OAAI
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection

在体液免疫受损和持续SARS-CoV-2感染的患者中,使用雷姆地西韦和尼罗韦/利托那韦进行双重联合抗病毒治疗

2023-07-1516
OAAI
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox
2023-06-1214
OAAI
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes

在意大利参考医院因新型冠状病毒肺炎住院的患者中,在Delta和Omicron共循环期间关注的SARS-CoV-2变异的演变: 对临床结果的影响

2023-05-296
OAAI